Risk Factors of Ototoxicity After Cisplatin-Based Chemo-Irradiation in Patients With Locally Advanced Head-and-Neck Cancer: A Multivariate Analysis
- 1 August 2007
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 68 (5) , 1320-1325
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- High‐dose superselective intra‐arterial cisplatin and concomitant radiation (radplat) for advanced head and neck cancerHead & Neck, 2004
- Miscellanea. Small-sample degrees of freedom with multiple imputationBiometrika, 1999
- Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective studyHead & Neck, 1999
- Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancerThe American Journal of Surgery, 1994
- Cisplatin ototoxicity in children: A practical grading systemMedical and Pediatric Oncology, 1991
- Predictive value of statistical modelsStatistics in Medicine, 1990
- High‐Dose cisplatin treatment: Hearing loss and plasma concentrationsThe Laryngoscope, 1990
- Ototoxicity of high‐dose cisplatin by bolus administration in patients with advanced cancers and normal hearingThe Laryngoscope, 1988
- Ototoxicity of cis-diamminedichloroplatinum (II): Influence of dose, schedule and mode of administrationEuropean Journal of Cancer and Clinical Oncology, 1983